
We know it hits poor people disproportionately, although it hits all people who are impacted.
On the public record
Every politician on the site, every statement on file. Search, filter, and read the public record.
38,800+·quotes on file

We know it hits poor people disproportionately, although it hits all people who are impacted.

And we know it is not a coincidence that disproportionately Black, Brown, and low income communities are more likely to struggle with extreme weather events fueled by climate change.

We are the first generation to suffer from climate change, but the last generation which can do anything about it.

I think that is something I completely agree with.

I ask unanimous consent that my chief of staff, Jon Donenberg, be allowed to join me on the floor. The ACTING PRESIDENT pro tempore. Without objection, it is so ordered. Tribute to Jon Donenberg

I can't support it, because the speaker is politicizing aid to Israel. He's politicizing our relationship. And fundamentally, politicizing our national security.

the GAO reported that private equity backed IRBs, I am going to quote here, 'are beholden to their clients or equity holders.'

I appreciate you raising this because I just want to make sure we get this right.

the GAO reported that private equity backed IRBs, I am going to quote here, 'are beholden to their clients or equity holders.'

I appreciate you raising this because I just want to make sure we get this right.

I have long described Federal support for medical research as one of the best investments that our Nation can make.

I have long described Federal support for medical research as one of the best investments that our Nation can make.

I appreciate you raising this because I just want to make sure we get this right.

The GAO found that an emphasis on profits can lead private equity backed IRBs to rubber stamp reviews of drug clinical trials.

According to a recent GAO report, despite representing just two percent of the review boards, these commercial IRBs now review over half of studies involving investigational new drugs.